755 (Temozolomide 180 mg)
Pill with imprint 755 is Orange & White, Capsule-shape and has been identified as Temozolomide 180 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma; melanoma, metastatic; anaplastic oligodendroglioma; melanoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for 755
Temozolomide
- Imprint:
- 755
- Strength:
- 180 mg
- Color:
- Orange & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Alkylating agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer:
- Cadila Healthcare Limited
- National Drug Code (NDC):
- 68382-0755
More about temozolomide
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 9 Reviews – Add your own review/rating
- Drug class: alkylating agents
Consumer resources
- Temozolomide
- Temozolomide Capsules
- Temozolomide Injection
- Temozolomide (Advanced Reading)
- Temozolomide Intravenous (Advanced Reading)
Other brands: Temodar
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
